8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

	February 6, 2013
	Date of Report (Date of earliest event reported)
	NU SKIN ENTERPRISES, INC.
	(Exact name of registrant as specified in its charter)
Delaware		001-12421	87-0565309
(State or other jurisdiction of incorporation)		(Commission File Number)	(IRS Employer Identification Number)
	75 West Center Street Provo, UT 84601
	(Address of principal executive offices and zip code)
	(801) 345-1000
	(Registrant's telephone number, including area code)
	N/A
	(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

□Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

□Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

□ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

□ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4 (c))

Item 2.02Results of Operations and Financial Condition.

On February 6, 2013, Nu Skin Enterprises, Inc. (the "Company") issued a press release announcing its financial results for the fourth quarter and year ended December 31, 2012, and certain other information.  A copy of the Company's press release is attached as Exhibit 99.1 to this report and incorporated by reference.

The information furnished pursuant to this Item 2.02 and the exhibit hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act except as shall be expressly set forth by specific reference in such filing.

The press release furnished herewith in Exhibit 99.1 contains certain operating income and earnings per share results that exclude certain expenses as indicated in the release.  Management believes these non-GAAP financial measures assist management and investors in evaluating, and comparing from period to period, results from ongoing operations in a more meaningful and consistent manner while also highlighting more meaningful trends in the results of operations.  A reconciliation of each non-GAAP financial measure to GAAP is provided in the press release furnished herewith.

Item 9.01 Financial Statements and Exhibits.

(c)Exhibit.

99.1 Nu Skin Enterprises' press release dated February 6, 2013, regarding financial results for the fourth quarter and year ended December 31, 2012.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

NU SKIN ENTERPRISES, INC. (Registrant)

/s/ Ritch Wood

Ritch Wood Chief Financial Officer

Date:  February 6, 2013

EXHIBIT INDEX

Exhibit No.Exhibit Description

99.1 Nu Skin Enterprises' press release dated February 6, 2013, regarding financial results for the fourth quarter and year ended December 31, 2012.

EX-99.1

FOR IMMEDIATE RELEASE

CONTACTS:

Investors — Scott Pond (801) 345-2657, spond@nuskin.comMedia — Kara Schneck (801) 345-2116, kschneck@nuskin.com

NU SKIN ENTERPRISES INCREASES 2013 GUIDANCE AND REPORTS RECORD

FOURTH-QUARTER AND 2012 RESULTS

PROVO, Utah — Feb. 6, 2013 — Nu Skin Enterprises, Inc. (NYSE: NUS) today announced record fourth-quarter results with revenue of $588.2 million, a 19 percent improvement over the prior-year period. Revenue was not materially impacted by foreign currency fluctuations. Earnings per share for the quarter were $0.97, a 27 percent year-over-year improvement. Additionally, the company announced that it is increasing its full-year 2013 revenue guidance by $50 million to $2.30 to $2.35 billion. The company expects 2013 earnings per share to be in the range of $3.77 to $3.92 with an anticipated negative foreign currency impact of 3 to 4 percent.

The company reported full year 2012 revenue of $2.17 billion, a 24 percent year-over-year improvement. Annual revenue was negatively impacted 1 percent by foreign currency fluctuations. Earnings per share for the year were $3.52, a 48 percent increase over 2011, or 31 percent when excluding charges related to a Japan customs case in the prior year.

"We are pleased with our solid fourth-quarter results and believe 2013 will be another record year as we launch a new wave of compelling anti-aging products and project strong performances around the world," said Truman Hunt, president and chief executive officer. "Our growth in the fourth quarter was driven by particularly strong trends in several key markets including Japan, South Korea and Mainland China where we continue to see tremendous results from our latest ageLOC products. We expect the upcoming launch of our ageLOC weight-management system to drive significant growth in the back-half of the year."

-more-

Nu Skin Enterprises, Inc.

Feb. 6, 2013Page 2

Regional Results

North Asia. Fourth-quarter revenue in North Asia was $250.2 million, compared to $204.3 million for the same period in 2011. The region's results were negatively impacted approximately 1 percent by foreign currency fluctuations. Japan local-currency revenue improved 26 percent while South Korea experienced local-currency revenue growth of 19 percent. The number of sales leaders in the region was up 14 percent while the number of actives improved 3 percent.

Greater China. In Greater China, fourth-quarter revenue increased 28 percent to $141.7 million, compared to $110.6 million in the prior-year period. Foreign currency fluctuations had a positive impact of 3 percent in the region. The sales leader count in the region improved 57 percent, while the number of actives increased 51 percent compared to the prior-year.

South Asia/Pacific. Revenue in South Asia/Pacific was $63.5 million, a 3 percent decline compared to the prior year. Sales in the quarter were positively impacted 4 percent by foreign currency fluctuations. The region's fourth-quarter sales leaders declined 11 percent while actives decreased 1 percent compared to the same period in 2011.

Americas. Revenue in the Americas improved 4 percent to $80.1 million, compared to $76.9 million in the prior-year period. Sales in the U.S. increased 18 percent when excluding $12.5 million of convention sales to non-U.S. distributors in the fourth quarter of 2011. The number of sales leaders improved 19 percent while the number of actives decreased 1 percent compared to the prior year.

Europe. Revenue in Europe was $52.8 million, a 38 percent improvement over the prior-year period. Results in the region were negatively impacted 6 percent by foreign currency fluctuations. Sales leaders and actives in Europe increased 21 and 9 percent, respectively, compared to the prior year.

Operational Performance

The company's operating margin was 15.1 percent for the quarter, compared to 15.3 percent in the prior year. Operating margin for the year was 15.7 percent compared to 13.4 percent in 2011, or 15.3 percent when excluding charges related to a Japan customs case in the prior year. Gross margin during the quarter was 83.8 percent, consistent with the prior year. Selling expenses, as a percent of revenue, were 45.0 percent in the fourth quarter, representing a 170 basis-point increase. The increase was driven by accelerated sales growth in many markets, due in part to successful product launches and a higher number of sales leaders qualifying for promotional incentives. General and administrative expenses, as a percent of revenue, were 23.8 percent, improving 150 basis-points over the prior year. Other income and expenses reflected a gain of $2.9 million.

-more-

Nu Skin Enterprises, Inc.

Feb. 6, 2013Page 3

The company's income tax rate for the quarter was 35.5 percent compared to 34.9 percent in the prior-year period. The company's cash and short-term investment position at the end of the quarter was $333.4 million. Dividend payments during the quarter were $11.7 million, and the company repurchased $21.9 million of its outstanding shares. During 2012 the company repurchased approximately $200 million of its outstanding shares.

Outlook

"We expect 2013 will be another record year with healthy trends in all of our regions and a record launch of our new ageLOC weight management system, which we plan to introduce through a global limited time offer in the fall," said Hunt.

"We also recently announced plans to increase our 2013 dividends by 50 percent, which represents a 140 percent increase in dividends over the past three years. With our strong performance and increasing cash flow, we have the financial flexibility to further increase our dividends, repurchase additional shares and continue to invest in important business initiatives to sustain growth," Hunt concluded.

"Based on the strength of our business and the growth of our global sales force, we are raising our expectations for 2013," said Ritch Wood, chief financial officer. "We expect first-quarter 2013 revenue to be $500 to $510 million, and are increasing our annual revenue guidance to $2.30 to $2.35 billion. First-quarter revenue guidance anticipates a 3 percent negative impact from foreign currency and annual guidance anticipates a 3 to 4 percent negative foreign currency impact. We expect earnings per share to be $0.75 to $0.77 for the first quarter, and $3.77 to $3.92 for the year."

-more-

Nu Skin Enterprises, Inc.

Feb. 6, 2013Page 4

The company's management will host a webcast with the investment community on Feb. 6, 2013, at noon EST. Those wishing to access the webcast, as well as the financial information presented during the call, can visit the Investor Relations page on Nu Skin Enterprises' website, http://ir.nuskin.com. An archive of the webcast will be available at this same URL through Feb. 22, 2013.

About Nu Skin Enterprises, Inc.

Nu Skin Enterprises, Inc. demonstrates its tradition of innovation through its comprehensive anti-aging product portfolio, independent business opportunity and corporate social responsibility initiatives. The company's scientific leadership in both skin care and nutrition has established Nu Skin as a premier anti-aging company. The company's anti-aging products feature the new ageLOC^® suite of products including the ageLOC^® R² nutritional supplement, ageLOC^® Galvanic Spa System and ageLOC^® Galvanic Body Spa™, as well as the ageLOC^® Transformation daily skin care system. A global direct selling company, Nu Skin operates in 53 markets worldwide and is traded on the New York Stock Exchange under the symbol "NUS." More information is available at http://www.nuskin.com.

Please Note: This press release, particularly the "Outlook" section, contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended that represent the company's current expectations and beliefs. All statements other than statements of historical fact are "forward-looking statements" for purposes of federal and state securities laws and include, but are not limited to, statements of management's expectations regarding the company's performance, initiatives, strategies and new product introductions; statements of projections regarding revenue, earnings per share, foreign currency impact, the amount and timing of future dividend payments and other financial items; statements of belief; and statements of assumptions underlying any of the foregoing. In some cases, you can identify these statements by forward-looking words such as "believe," "expect," "project," "anticipate," "estimate," "intend," "plan," "targets," "likely," "will," "would," "could," "may," "might," the negative of these words and other similar words.

The forward-looking statements and related assumptions involve risks and uncertainties that could cause actual results and outcomes to differ materially from any forward-looking statements or views expressed herein. These risks and uncertainties include, but are not limited to, the following:

· the actual declaration and payment of the planned dividends by the Board of Directors is subject to any changes in the company's net earnings, financial condition, cash requirements, future prospects or other factors deemed relevant by the company's Board of Directors that could cause the Board of Directors to reduce or discontinue the payment of currently planned quarterly dividends;

· any failure of current or planned initiatives or products to generate interest among distributors and customers and generate sponsoring and selling activities on a sustained basis;

· risks related to accurately predicting, delivering or maintaining sufficient quantities of products to support our planned initiatives or launch strategies, including possible ingredient supply limitations;

-more-

Nu Skin Enterprises, Inc.

Feb. 6, 2013Page 5

· challenging economic conditions globally;

· risk of foreign currency fluctuations and the currency translation impact on the company's business associated with these fluctuations;

· risks associated with general inquiries and complaints to consumer protection agencies in Japan regarding the activities of some distributors;

· regulatory risks associated with the company's products, which could require the company to modify its claims or inhibit the company's ability to import or continue selling a product in a market if it is determined to be a medical device or if it is unable to register the product in a timely manner under applicable regulatory requirements;

· continued regulatory scrutiny and investigations in Mainland China, which have from time to time in the past, and could in the future, negatively impact the company's business, including the interruption of sales activities in stores, loss of licenses, and the imposition of fines;

· adverse publicity related to the company's business, products, industry or any legal actions or complaints by distributors or others;

· any prospective or retrospective increases in duties on the company's products imported into the company's markets outside of the United States and any adverse results of tax audits or unfavorable changes to tax laws in the company's various markets; and

· continued competitive pressures in the company's markets.

The company's financial performance and the forward-looking statements contained herein are further qualified by a detailed discussion of associated risks set forth in the documents filed by the company with the Securities and Exchange Commission.  The forward-looking statements set forth the company's beliefs as of the date that such information was first provided and the company assumes no duty to update the forward-looking statements contained in this release to reflect any change except as required by law.

-more-

Nu Skin Enterprises, Inc.

Feb. 6, 2013Page 6

NU SKIN ENTERPRISES, INC.
Consolidated Statements of Income (Unaudited)
For the Fourth Quarters Ended December 31, 2012 and 2011
(in thousands, except per share amounts)
	2012		2011
Revenue:
North Asia	$	250,195	$	204,312
Greater China		141,668		110,555
South Asia/Pacific		63,451		65,235
Americas		80,147		76,893
Europe		52,784		38,309
Total revenue		588,245		495,304
Cost of sales		95,044		80,171
Gross profit		493,201		415,133
Operating expenses:
Selling expenses		264,620		214,603
General and administrative expenses		139,679		124,954
Total operating expenses		404,299		339,557
Operating income		88,902		75,576
Other income (expense), net		2,893		455
Income before provision for income taxes		91,795		76,031
Provision for income taxes		32,562		26,508
Net income	$	59,233	$	49,523
Net income per share:
Basic	$	1.01	$	0.80
Diluted	$	0.97	$	0.76
Weighted average common shares outstanding:
Basic		58,620		62,268
Diluted		60,893		64,876

-more-

Nu Skin Enterprises, Inc.

Feb. 6, 2013Page 7

NU SKIN ENTERPRISES, INC.
Consolidated Statements of Income (Unaudited)
For the Years Ended December 31, 2012 and 2011
(in thousands, except per share amounts)
	2012		2011
Revenue:
North Asia	$	794,833	$	751,165
Greater China		570,640		341,919
South Asia/Pacific		330,240		236,212
Americas		288,732		251,984
Europe		185,219		162,711
Total revenue		2,169,664		1,743,991
Cost of sales		353,152		322,624
Gross profit		1,816,512		1,421,367
Operating expenses:
Selling expenses		970,219		751,448
General and administrative expenses		505,449		436,177
Total operating expenses		1,475,668		1,187,625
Operating income		340,844		233,742
Other income (expense), net		4,398		(6,973	)
Income before provision for income taxes		345,242		226,769
Provision for income taxes		123,597		73,439
Net income	$	221,645	$	153,330
Net income per share:
Basic	$	3.66	$	2.47
Diluted	$	3.52	$	2.38
Weighted average common shares outstanding:
Basic		60,600		62,066
Diluted		63,025		64,546

-more-

Nu Skin Enterprises, Inc.

Feb. 6, 2013Page 8

NU SKIN ENTERPRISES, INC.
Consolidated Balance Sheets (Unaudited)
As of December 31, 2012 and 2011
(in thousands)
	2012			2011
ASSETS
Current assets:
Cash and cash equivalents	$	320,025		$	272,974
Current investments		13,378			17,727
Accounts receivable		36,850			31,615
Inventories, net		135,874			112,111
Prepaid expenses and other		93,276			95,660
		599,403			530,087
Property and equipment, net		229,787			149,505
Goodwill		112,446			112,446
Other intangible assets, net		92,518			83,333
Other assets		118,753			115,585
Total assets	$	1,152,907		$	990,956
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable	$	47,882		$	32,181
Accrued expenses		233,202			180,382
Current portion of long-term debt		39,019			28,608
		320,103			241,171
Long-term debt		154,963			107,944
Other liabilities		87,229			67,605
Total liabilities		562,295			416,720
Stockholders' equity:
Class A common stock		91			91
Additional paid-in capital		317,293			292,240
Treasury stock, at cost		(714,853	)		(522,162	)
Accumulated other comprehensive loss		(51,822	)		(62,565	)
Retained earnings		1,039,903			866,632
		590,612			574,236
Total liabilities and stockholders' equity	$	1,152,907		$	990,956

-more-

Nu Skin Enterprises, Inc.

Feb. 6, 2013Page 9

NU SKIN ENTERPRISES, INC.
Actives/Sales Leaders Statistics
	As of December 31, 2012				As of December 31, 2011				% Increase (Decrease)
	Actives		Sales Leaders		Actives		Sales Leaders		Actives		Sales Leaders
North Asia		349,000		17,395		338,000		15,293		3.3%		13.7%
Greater China		216,000		18,527		143,000		11,808		51.0%		56.9%
South Asia/Pacific		98,000		4,988		99,000		5,619		(1.0%)		(11.2%)
Americas		164,000		6,352		166,000		5,356		(1.2%)		18.6%
Europe		119,000		4,528		109,000		3,740		9.2%		21.1%
Total		946,000		51,790		855,000		41,816		10.6%		23.9%

"Actives" include our independent distributors and preferred customers who have purchased products for resale or personal consumption during the previous three months.

"Sales Leaders" include our independent distributors who have completed and who maintain specified sales requirements. "Sales Leaders" also include our qualified sales employees and contractual sales promoters in China.

NU SKIN ENTERPRISES, INC. Reconciliation of Operating Income as Reported to Operating Income Excluding Japan Customs Expense
(in thousands)
	Year Ended December 31,
	2012		2011
Revenue as reported	$	2,169,664	$	1,743,991
Operating income as reported	$	340,844	$	233,742
Japan customs expense	─			32,754
Operating income excluding Japan customs expense	$	340,844	$	266,496
Operating income as a percent of revenue as reported		15.7%		13.4%
Operating income as a percent of revenue excluding Japan customs expense		15.7%		15.3%

-more-

Nu Skin Enterprises, Inc.

Feb. 6, 2013Page 10

NU SKIN ENTERPRISES, INC. Reconciliation of Diluted Earnings Per Share as Reported to Diluted Earnings Per Share Excluding Japan Customs Expense
(in thousands)
	Year Ended December 31,
	2012		2011
Net income as reported	$	221,645	$	153,330
Japan customs expense	─			32,754
Tax effect of Japan customs expense	─			(12,276	)
Net income excluding Japan customs expense	$	221,645	$	173,808
Diluted earnings per share as reported	$	3.52	$	2.38
Diluted earnings per share, excluding Japan customs expense	$	3.52	$	2.69

###